PTC Therapeutics Inc Cash Flow-to-Debt Ratio
PTC Therapeutics Inc cash flow-to-debt ratio. PTC Therapeutics Inc (PTCT) has a Cash Flow-to-Debt Ratio of -0.02x as of March 2026, meaning its operating cash flow of $-59.04 Million could theoretically repay 0% of its total liabilities ($3.05 Billion) in one year. Check how aggressively does PTC Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of PTC Therapeutics Inc (2011–2025)
Cash flow-to-debt ratio of PTC Therapeutics Inc from 2011 to 2025. Historical debt coverage capacity for PTC Therapeutics Inc across 15 annual periods. Check how high is PTC Therapeutics Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
PTC Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2011–2025)
PTC Therapeutics Inc cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for PTC Therapeutics Inc. For the full cash flow conversion analysis, see PTC Therapeutics Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | $711.20 Million | $3.12 Billion | ▲ +694.0% |
| 2024 | -0.04x | $-107.69 Million | $2.80 Billion | ▲ +34.2% |
| 2023 | -0.06x | $-158.42 Million | $2.71 Billion | ▲ +66.4% |
| 2022 | -0.17x | $-356.65 Million | $2.05 Billion | ▼ -33.9% |
| 2021 | -0.13x | $-251.33 Million | $1.94 Billion | ▼ -15.4% |
| 2020 | -0.11x | $-194.07 Million | $1.73 Billion | ▼ -17.3% |
| 2019 | -0.10x | $-98.64 Million | $1.03 Billion | ▼ -166.4% |
| 2018 | -0.04x | $-27.64 Million | $768.50 Million | ▲ +15.9% |
| 2017 | -0.04x | $-10.06 Million | $235.22 Million | ▲ +93.8% |
| 2016 | -0.69x | $-103.57 Million | $149.76 Million | ▲ +61.3% |
| 2015 | -1.79x | $-124.34 Million | $69.57 Million | ▼ -8.4% |
| 2014 | -1.65x | $-57.27 Million | $34.75 Million | ▲ +46.0% |
| 2013 | -3.05x | $-46.92 Million | $15.36 Million | ▼ -105.7% |
| 2012 | -1.49x | $-47.93 Million | $32.27 Million | ▼ -1922.4% |
| 2011 | -0.07x | $-20.77 Million | $282.75 Million | — |